Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 103.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.41% |
| Mar 31, 2026 | 320.11% |
| Dec 31, 2025 | -108.42% |
| Sep 30, 2025 | 228.83% |
| Jun 30, 2025 | 62.21% |
| Mar 31, 2025 | -336.68% |
| Dec 31, 2024 | 81.13% |
| Sep 30, 2024 | -33.09% |
| Jun 30, 2024 | 100.57% |
| Mar 31, 2024 | -96.13% |
| Dec 31, 2023 | 100.98% |
| Sep 30, 2023 | -90.95% |
| Jun 30, 2023 | -2,434.34% |
| Mar 31, 2023 | 59.27% |
| Dec 31, 2022 | -3,037.24% |
| Sep 30, 2022 | 440.57% |
| Jun 30, 2022 | 199.52% |
| Mar 31, 2022 | 315.08% |
| Dec 31, 2021 | 233.36% |
| Sep 30, 2021 | 35.18% |